LYSODREN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Mitotane.
| Product ID | 0015-3080_bacf9c5c-6119-4219-8d8d-f3c2db33e18e |
| NDC | 0015-3080 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LYSODREN |
| Generic Name | Mitotane |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-06-01 |
| Marketing End Date | 2021-03-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA016885 |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | MITOTANE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Cytochrome P450 3A4 Inducers [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2009-06-01 |
| Marketing End Date | 2021-03-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA016885 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-06-01 |
| Marketing End Date | 2021-03-31 |
| Ingredient | Strength |
|---|---|
| MITOTANE | 500 mg/1 |
| SPL SET ID: | e9fba7d4-a0ec-4bfa-9b5b-ec97a9710fd3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0015-3080 | LYSODREN | MITOTANE |
| 76336-080 | Lysodren | mitotane |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LYSODREN 73358100 1243390 Live/Registered |
Bristol-Myers Company 1982-04-05 |
![]() LYSODREN 73156066 1099245 Live/Registered |
CALBIOCHEM-BEHRING CORP. 1978-01-23 |